Evaluate your liver's detoxification capacity and synthetic function. Advanced screening for MASLD, biliary health, and hepatic insulin resistance.
We've ranked these offers by total price (Base + Fees). Prices are updated daily directly from the labs.
What this test is for, how to prepare, and what the results may imply—plus quick logistics for ordering.
This panel breaks down into three distinct physiological categories: Hepatocellular (liver cell) injury, Cholestatic (biliary/bile duct) flow, and Hepatic Synthetic capacity.
ALT (Alanine Aminotransferase): This enzyme is primarily localized in the cytosol of liver cells. When liver cells are stressed or inflamed (from sugar, alcohol, viruses, or hepatotoxic supplements), they rupture and leak ALT into the bloodstream. In metabolic optimization, an ALT over 25 U/L for women or 33 U/L for men is a clinical red flag for early-stage liver fat accumulation, regardless of what "normal" lab ranges state.
AST (Aspartate Aminotransferase): While present in the liver, AST is also highly concentrated in the mitochondria of skeletal muscle and cardiac tissue. Therefore, isolated high AST without high ALT might indicate intense muscle breakdown from exercise rather than liver disease.
The AST/ALT (De Ritis) Ratio: This ratio is a profound diagnostic tool. An AST/ALT ratio > 1.0 (with both elevated) often points to alcohol-induced liver stress or advanced fibrosis. A ratio < 1.0 (where ALT is significantly higher than AST) is the classic biochemical signature of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
Alkaline Phosphatase (ALP): An enzyme concentrated in the bile ducts (and bones). When bile flow becomes sluggish or obstructed (cholestasis)—often due to gallstones or thickened bile—ALP rises. It is a critical marker for gallbladder health and toxin excretion.
Bilirubin (Total, Direct, and Indirect): A yellowish pigment created when the spleen breaks down old red blood cells. The liver must "conjugate" (make water-soluble) this pigment to excrete it in bile. Interestingly, mild, chronic elevations of unconjugated (indirect) bilirubin—often diagnosed as benign Gilbert's Syndrome—are now recognized by biohackers as a massive cardiovascular advantage, as bilirubin is one of the most potent endogenous antioxidants in the human body.
Albumin: The liver is a protein factory. Albumin is its primary product, acting as a massive cargo ship in your blood. It transports hormones (like testosterone and thyroid hormone), fatty acids, and medications. High-normal Albumin (typically >4.5 g/dL) is a hallmark of robust longevity, adequate amino acid intake, and a highly functioning liver. Low albumin is a lagging indicator of severe liver dysfunction or systemic inflammation.
Your liver is the master biochemical refinery of the human body, performing over 500 critical functions ranging from deep cellular detoxification to macronutrient partitioning and hormone clearance.
The Hepatic Function Panel (HFP) is far more than a simple "damage check" for heavy drinkers. In modern functional medicine, it is a primary diagnostic tool for assessing metabolic flexibility. The enzymes and proteins measured in this panel reveal the early, silent progression of ectopic fat storage in the liver, the efficiency of your biliary (bile) flow, and your liver's capacity to synthesize the transport proteins necessary for a long, healthy lifespan.
This test is an absolute necessity for biohackers mapping their metabolic flexibility, athletes pushing their physical limits, and anyone seeking to reverse prediabetes, as the liver is the primary organ dictating systemic insulin resistance.
You should prioritize this hepatic evaluation when:
The Muscle Breakdown Confound: As mentioned, AST is not liver-specific. If your AST is elevated but ALT, ALP, and Bilirubin are perfectly normal, the liver is likely not the issue. The elevation is almost certainly from muscle breakdown. In such cases, a follow-up Creatine Kinase (CK) test should be ordered to confirm muscle origin and prevent an unnecessary liver biopsy or panic.
2025–2026 Clinical Breakthroughs: